Complete Filing Data
BM Acquisition Corp. reported Net Income Loss of -$5.6 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BM Acquisition Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income Loss | -$5.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 |
|---|---|
| Net Income Loss | -$71.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stockholders Equity | -$63.2K |
| Retained Earnings Accumulated Deficit | -$88.2K |
| Notes Payable Current | $627.9K |
| Liabilities Current | $678.2K |
| Liabilities And Stockholders Equity | $615.0K |
| Deferred Offering Costs Included In Promissory Note | |
| Assets | $615.0K |
| Additional Paid In Capital Common Stock | $24.8K |
| Subscription Receivable | |
| Deferred Offering Costs | |
| Accrued Offering Costs Current | $50.3K |
| Deferred Costs | $590.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $25.0K |
| Assets Current | $25.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Stockholders Equity | -$77.3K | |
| Retained Earnings Accumulated Deficit | -$77.3K | -$5.6K |
| Notes Payable Current | $511.0K | $78.6K |
| Liabilities Current | $543.4K | $78.6K |
| Liabilities And Stockholders Equity | $466.1K | $73.0K |
| Deferred Offering Costs Included In Promissory Note | $73.0K | |
| Assets | $466.1K | $73.0K |
| Additional Paid In Capital Common Stock | $24.8K | $24.8K |
| Subscription Receivable | -$25.0K | -$25.0K |
| Deferred Offering Costs | $466.1K | $73.0K |
| Accrued Offering Costs Current | $32.4K | |
| Deferred Costs | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | ||
| Assets Current |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stock Issued During Period Shares Share Based Compensation Forfeited | 225.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 |
|---|---|
| Stock Issued During Period Shares Share Based Compensation Forfeited | 225.0K |
Per-Share & Share Counts
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.7M | 1.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 1.7M | 1.7M |
| Earnings Per Share Diluted | $-0.04 | $0.00 |
| Earnings Per Share Basic | $-0.04 | $0.00 |
Other Metrics
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 |
|---|---|
| Formation And Operating Costs | $5.6K |
Most recent annual filing with the SEC: March 16, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.